Medicare can cover an Alzheimer's evaluation that includes the Mini-Mental State Examination (MMSE), but it does not treat the MMSE as a separate covered benefit. Instead, Medicare Part B may cover the broader visit in which a clinician evaluates cognitive impairment and develops a care plan. The MMSE is a brief test of abilities such as memory, attention, and orientation. Whether Medicare pays depends on the purpose of the visit, the service billed, and whether the medical record supports the need for evaluation.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Check eligibility on CMS’s official study page — Use this page to check the study’s participation requirements.
- Read the official guidance from Medicare — Use this primary source to verify the official guidance.
Table of Contents
- What Medicare actually covers
- What happens during a wellness or routine visit
- Who may qualify for the detailed assessment
- What could you owe?
- Why an MMSE result is not a diagnosis
What Medicare actually covers
medicare.gov confirms that Part B covers a separate cognitive-assessment and care-planning visit. The visit can help establish or confirm Alzheimer's disease or another dementia diagnosis and create a care plan. Clinicians bill this service using CPT 99483, a medical billing code for a comprehensive cognitive assessment.
The MMSE may be one part of that evaluation, but the covered service is the full clinical assessment—not the brief test by itself. CMS explains that CPT 99483 includes cognitive, functional, safety, medication, behavioral, and dementia-staging assessments. It also requires information from an independent historian, such as a family member or caregiver, and a written care plan.
What happens during a wellness or routine visit
The Medicare Annual Wellness Visit requires the provider to check for possible cognitive impairment. CMS does not require the provider to use the MMSE. The provider may rely on direct observation, reports from the patient or someone close to them, and an appropriate brief test. A clinician may also use a brief cognitive test during a routine visit.
If the results or reported changes suggest impairment, the clinician can arrange the more detailed cognitive-assessment service. This distinction matters for billing. A quick MMSE during another appointment is not necessarily a separate charge or separately covered service. ask which visit or billing code the practice plans to use.
Who may qualify for the detailed assessment
CPT 99483 is available for beneficiaries with cognitive impairment. That includes people with diagnosed Alzheimer's disease, another dementia, mild cognitive impairment, or clinician-identified impairment without a firm diagnosis. Coverage is based on evaluation and care needs, not merely a request for general Alzheimer's screening.
A current Palmetto GBA Medicare contractor policy states that the Folstein MMSE and similar screening tests are included in the clinical interview or evaluation service rather than separately reimbursed. The same policy excludes testing performed solely as Alzheimer's screening. Clear documentation can therefore matter. The medical record should explain the suspected impairment, relevant symptoms, why assessment is medically necessary, and how the results may affect management.
What could you owe?
After the Part B deductible, a beneficiary generally pays 20% of the Medicare-approved amount for the cognitive-assessment service. The final cost can also depend on whether the provider accepts assignment, where the service occurs, other charges, and supplemental insurance. Before the appointment, ask the practice:.
- Whether it expects to bill CPT 99483
- Whether the clinician accepts Medicare assignment
- Whether the MMSE is included in another billed visit
- Whether a facility fee or additional testing may apply
- Whether supplemental coverage is expected to pay part of the balance
Why an MMSE result is not a diagnosis
An MMSE score cannot establish Alzheimer's disease by itself. The National Institute on Aging explains that clinicians combine cognitive testing with medical history, functional information, medical tests, psychiatric evaluation, and sometimes imaging or biomarkers. A low score can signal the need for more evaluation, while one brief test does not settle the cause of a person's difficulties.
The broader assessment examines how cognition affects daily life, safety, medication use, behavior, and care needs. Before the visit, gather a current medication list and examples of changes that prompted concern. If possible, bring someone who knows the person's everyday functioning and can provide the independent history required for CPT 99483.
